SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-000855
Filing Date
2022-01-06
Accepted
2022-01-06 17:20:14
Documents
16
Period of Report
2021-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10032547_8k.htm   iXBRL 8-K 39470
2 EXHIBIT 10.1 brhc10032547_ex10-1.htm EX-10.1 177505
3 EXHIBIT 99.1 brhc10032547_ex99-1.htm EX-99.1 7526
4 EXHIBIT 99.2 brhc10032547_ex99-2.htm EX-99.2 7113
8 image00001.jpg GRAPHIC 7467
  Complete submission text file 0001140361-22-000855.txt   434069

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cemi-20211230.xsd EX-101.SCH 3920
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemi-20211230_lab.xml EX-101.LAB 22544
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemi-20211230_pre.xml EX-101.PRE 16040
10 EXTRACTED XBRL INSTANCE DOCUMENT brhc10032547_8k_htm.xml XML 4053
Mailing Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788
Business Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788 (631) 924-1135
CHEMBIO DIAGNOSTICS, INC. (Filer) CIK: 0001092662 (see all company filings)

IRS No.: 880425691 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35569 | Film No.: 22515638
SIC: 2834 Pharmaceutical Preparations